Gold Edges Higher, Supported by Fed Rate-Cut Prospects
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a few seconds ago
- Business Wire
G42 Launches OpenAI GPT-OSS Globally on Core42's AI Cloud
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)-- Core42, a G42 company specializing in sovereign cloud and AI infrastructure, announced the availability of OpenAI's latest open-weight AI models, including gpt-oss-20B and gpt-oss-120B, on the Core42 AI Cloud platform, instantly accessible through the Core42 Compass API. The deployment enables enterprises, researchers, and developers to run the models on a choice of leading silicon platforms with sovereign, scalable, and high-performance capabilities. Integrated into Compass API with the flexibility to access a wide spectrum of high-performance compute platforms, Core42 delivers industry-leading inference speeds of up to 3,000 tokens per second per user, enabling real-time AI at global scale while aligning workloads with the optimal infrastructure for price-performance and scalability. This deployment delivers tailored performance for low-latency inference workloads and applications, reinforcing Core42's commitment to secure and optimized global sovereign-enabled AI infrastructure. 'Core42 AI Cloud, powered by silicon-diverse infrastructure, delivers the flexibility and performance needed for today's AI workloads,' said Kiril Evtimov, CEO of Core42 and Group CTO, G42. 'Through the Compass API, organizations can access the latest open-weight AI models and choose the optimal platform to scale transformation, optimize performance and cost, and drive progress across global markets.' Key Benefits of Core42's Open-Weight Deployment: Enterprise-scale performance – Run the fastest, most demanding workloads at global scale, enabling advanced automation, decision-making, and real-time AI experiences. Sovereign-ready scalability – Deploy high-performance AI in-country with full sovereign controls, supporting secure operations in regulated sectors such as healthcare, finance, and national security. Optimized for committed environments – Deliver fast, scalable AI in-country with sovereign controls for organizations operating under committed infrastructure agreements, ensuring predictable cost and performance. Cost-efficient agentic AI – Run agentic workloads at the lowest possible cost while maintaining in-country deployment and sovereign controls, making advanced AI accessible to cost-sensitive use cases. Available now through Compass API, these models let organizations run and adapt AI locally or in the cloud, with full transparency, fine-tuning, and sovereign deployment options. Customers can align performance, cost, and compliance to their needs. This release marks a pivotal move toward enterprise AI autonomy. With open-weight access, businesses can shape AI to their unique needs and unlock new possibilities for innovation at scale. This announcement builds on G42's recent milestones, including the unveiling of a 5GW US-UAE AI campus and the launch of the 1GW Stargate UAE facility as Phase 1 of the project, as well as a $1.5 billion investment from Microsoft in 2024, reinforcing the UAE's role as a global AI hub. For more information, visit and About Core42 Core42, a G42 company, empowers individuals, enterprises, and nations to unlock the full potential of AI through its comprehensive enablement capabilities. As a leading provider of sovereign cloud, AI infrastructure, and services, our mission is to accelerate the achievements of others and help them reach their most ambitious goals. To learn more, please visit and follow Core42 LinkedIn, Core42 Instagram, Core42 X About G42 G42 is a global leader in creating visionary artificial intelligence capabilities for a better tomorrow. Born in Abu Dhabi and operating around the world, G42 champions AI as a powerful force for good. Its people are constantly reimagining what technology can do, applying advanced thinking and innovation to accelerate progress and tackle society's most pressing problems. G42 is joining forces with nations, corporations and individuals to create the infrastructure for tomorrow's world. From molecular biology to space exploration and everything in between, G42 realizes exponential possibilities, today. For further information visit Source: AETOSWire
Yahoo
29 minutes ago
- Yahoo
Leerink Partners Reiterates a Buy Rating on NovoCure Limited (NVCR)
NovoCure Limited (NASDAQ:NVCR) is one of the . Leerink Partners analyst Jonathan Chang reiterated a Buy rating on NovoCure Limited (NASDAQ:NVCR) on July 24, setting a price target of $33.00. A researcher looking through a microscope at a sample in the lab. The analyst told investors that NovoCure Limited (NASDAQ:NVCR) reported solid results for fiscal Q2 2025, exceeding revenue expectations with a total of $158.8 million. This growth was attributed to a rise in active patient numbers across major markets, suggesting solid demand for the products. Chang added that despite the initial mixed metrics for the launch of Optune Lua in non-small cell lung cancer (NSCLC), prescriptions and active patients underwent a notable growth, suggesting potential for future growth. NovoCure Limited (NASDAQ:NVCR) develops, manufactures, and commercializes Optune to treat a number of solid tumors. The company's platform is called Tumor Treating Field, and it employs electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. While we acknowledge the potential of NVCR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the . On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT), keeping the associated price target at $83. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. He based the optimistic rating on the stability and growth of PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) performance, stating that the company reported a 4% sales beat in Q2. This growth was attributed to strong international momentum and higher average selling prices in the US. The analyst added that the company's full-year sales guidance was raised slightly despite a softer Q3, and the gross margin guidance was improved as well. This suggests a positive outlook for the rest of the year, according to the analyst. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage surgical robotics company that develops transformative solutions for urology. The company manufactures and sells the AquaBeam Robotic System, which is an image-guided, surgical robotic system used in minimally invasive urologic surgery. While we acknowledge the potential of PRCT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
